Top Markets
Coin of the day
Jiangsu Hengrui Medicine Co., Ltd. Jiangsu Hengrui Medicine Co., Ltd.

Jiangsu Hengrui Medicine Co., Ltd.

600276
Classifica tra le azioni #505
Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged... Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged in the full spectrum of pharmaceutical operations, from the initial discovery and development of medications to their manufacturing and worldwide distribution. The company is actively advancing a substantial pipeline of drug candidates, which includes Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403. These prospective treatments are aimed at a diverse range of medical conditions, primarily focusing on oncology, metabolic disorders, pain management, and autoimmune diseases, among others. The enterprise was founded in 1970 and maintains its corporate headquarters in Lianyungang, China.
Prezzo delle azioni
$7.99
Capitalizzazione di mercato
$50.98B
Variazione (1 giorno)
1.45%
Variazione (1 anno)
-8.42%
Paese
CN
Scambia Jiangsu Hengrui Medicine Co., Ltd. (600276)

Categoria

Storico del prezzo dell'azione per Jiangsu Hengrui Medicine Co., Ltd. (600276)
Prezzo di chiusura più alto: $7.92 il 2026-08-01

Prezzo di chiusura più basso: $0.04 il 2005-07-01
Storico del prezzo dell'azione di Jiangsu Hengrui Medicine Co., Ltd. dal 2005 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) -3.58%
2025 33.70%
2024 2.96%
2023 15.17%
2022 -30.24%
2021 -37.82%
2020 50.21%
2019 73.88%
2018 25.89%
2017 85.51%
2016 3.95%
2015 100.95%
2014 12.39%
2013 42.52%
2012 4.92%
2011 -16.03%
2010 40.18%
2009 61.62%
2008 -8.70%
2007 153.91%
2006 239.46%
2005 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$171.67 -
DE
$166.06 27.73%
DE
$36.26 22.57%
JP
$228.90 41.12%
CH
$21.46 14.45%
IN